AIG
INZY

American International Group’s Inozyme Pharma INZY Stock Holding History

American International Group’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,528
Closed -$180K – 1317
2024
Q1 		$180K Sell
23,528
-202
-0.9% -$1.11K ﹤0.01% 2214
2023
Q4 		$101K Buy
23,730
+6,838
+40% +$24.3K ﹤0.01% 2561
2023
Q3 		$70.9K Buy
16,892
+600
+4% +$3.05K ﹤0.01% 2700
2023
Q2 		$90.7K Buy
+16,292
New +$96.3K ﹤0.01% 2650
2022
Q2 		– Sell
-7,144
Closed -$29K – 3182
2022
Q1 		$29K Sell
7,144
-503
-7% -$2.96K ﹤0.01% 2981
2021
Q4 		$52K Sell
7,647
-228
-3% -$1.97K ﹤0.01% 2944
2021
Q3 		$91K Sell
7,875
-187
-2% -$2.92K ﹤0.01% 2839
2021
Q2 		$137 Buy
8,062
+1,051
+15% +$18.3K ﹤0.01% 2741
2021
Q1 		$139 Buy
7,011
+2,287
+48% +$50.5K ﹤0.01% 2550
2020
Q4 		$98 Sell
4,724
-136
-3% -$3.24K ﹤0.01% 2671
2020
Q3 		$128K Buy
+4,860
New +$121K ﹤0.01% 2394

Other funds holding INZY

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American International Group's INZY Position: Q2 2024 in Review

American International Group sold out of Inozyme Pharma (INZY) in Q2 2024, closing a stake of 23,528 shares — an estimated $180K sold.

American International Group first reported a position in INZY in Q3 2020 and held it in 11 quarters. The position peaked at $180K in Q1 2024. 90 funds tracked by Wall St. Rank hold INZY as of Q2 2024.

  • American International Group reported no remaining Inozyme Pharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 23,528 Inozyme Pharma shares in Q2 2024, an estimated $180K.
  • American International Group first reported a position in Inozyme Pharma in Q3 2020 and held it in 11 quarters.
  • American International Group's Inozyme Pharma position peaked at $180K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.